Short Sellers Are Taking Aim at Buy-Rated Tempus AI. Should You Buy TEM Stock Here? Tempus AI stock fell over 19% after Spruce Point Capital released a short report. Can TEM stock recover? Barchart · May 29, 2025
5 Momentum Stocks to Buy Now Amid volatile trade and rising uncertainty, these momentum stocks have shown strong signs of leadership in the first half of 2025. Kiplinger · May 21, 2025
Tempus AI Stock: Time to Double Down or Cut and Run? Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point to significant upside potential. MarketBeat · May 8, 2025
3 Hot New IPOs Defying the 2025 Market Slump Tempus AI, ServiceTitan, and CoreWeave are 2025 IPO standouts, defying a down market. Here’s how they’re beating the S&P 500 so far this year. MarketBeat · Apr 14, 2025
Nancy Pelosi's 2025 Stock Buys Worth $1.95M are Deep in Red, Some as Much as 57% Former House Speaker Nancy Pelosi purchased call option contracts of companies, including Alphabet, Amazon, Nvidia, Vistra Corp, and Tempus AI, in January. International Business Times UK · Apr 11, 2025
4 Healthcare Stocks With Massive Gains—and More to Come Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year. MarketBeat · Mar 29, 2025
Nancy Pelosi's Net Worth Has Dropped By £11.23M After Trump Took Office Nancy Pelosi's investments in top tech giants have markedly declined after Trump's tariff plans introduced volatility in stock markets. International Business Times UK · Mar 10, 2025
Cathie Wood Loves This Under-the-Radar AI Stock. Is It Time for You to Buy Now? The popular investor poured $366.2 million in the company’s shares to carry out her latest purchase. Barchart · Mar 3, 2025
Tempus AI Is a Buy, If You Can Handle the Volatility Tempus AI is well-positioned to capitalize on its extensive clinical data database. It can provide personalized treatment for hard-to-treat illness. MarketBeat · Feb 26, 2025
Nancy Pelosi's Tempus AI Stock Investment Jumps Over 300% in 40 Days Pelosi's Tempus AI call options contracts tripled in value in 40 days as the healthcare firm continued its upward rally on AI-product launches and active collaborations to battle diseases like cancer. International Business Times UK · Feb 24, 2025
Conflicting Signals: Tempus AI's Stock Market Rally Tempus AI's stock has soared on completed acquisitions and product launches, yet mixed analyst sentiment signals a need for careful investor review. MarketBeat · Feb 17, 2025
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024. MarketBeat · Jan 27, 2025
Pelosi Bets Big on AI: This Is What You Need to Know Congressional Whale Nancy Pelosi is in the spotlight, buying significant positions in tech stocks like NVDA and other AI plays. MarketBeat · Jan 22, 2025
Pelosi Sells 31K Apple and 10K Nvidia Shares, Eyes New AI and Utility Firm in a Major Portfolio Reshuffle Pelosi sold Apple and Nvidia shares while betting on Tempus AI and Vistra Corp. She also bought call options for both Amazon and Alphabet Class A stocks. International Business Times UK · Jan 21, 2025
MarketBeat · Dec 20, 2024 Tempus AI: A Potential Double-Bagger After Recent Pullback AI healthcare stock Tempus AI has seen its value fall off a cliff recently. However, Wall Street remains bullish, seeing significant upside in the shares.
Barchart · Dec 17, 2024 1 AI Stock Cathie Wood Is Buying Instead of Tesla Cathie Wood is shifting away from Tesla, zeroing in on an AI-driven healthcare firm that is revolutionizing precision medicine and advanced diagnostics.
Barchart · Aug 29, 2024 Should You Follow Cathie Wood Into This AI Diagnostics Stock? This AI diagnostics stock is a holding in Wood's ARKK and ARKG ETFs.